Silverarc Capital Management, LLC Evogene Ltd. Transaction History

Silverarc Capital Management, LLC

$298 Million
Q1 2024

A detailed history of Silverarc Capital Management, LLC transactions in Evogene Ltd. stock. As of the latest transaction made, Silverarc Capital Management, LLC holds 3,085,503 shares of EVGN stock, worth $2.01 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares

3,085,503

Previous 3,100,000 0.47%

Holding current value

$2.01 Million

Previous $2.6 Million 11.14%

% of portfolio

0.78%

Previous 0.82%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$0.7 - $0.98 $10,147 - $14,207	-14,497 Reduced 0.47%	3,085,503 $2.31 Million
Q3 2023 Nov 13, 2023	BUY	$0.58 - $1.41 $1.74 Million - $4.23 Million	3,000,000 Added 3000.0%	3,100,000 $1.83 Million
Q2 2023 Aug 14, 2023	BUY	$0.56 - $1.2 $56,000 - $120,000	100,000 New	100,000 $107,000
Q4 2022 Feb 14, 2023	SELL	$0.61 - $0.78 $10,460 - $13,376	-17,149 Reduced 10.24%	150,361 $105,000
Q3 2022 Oct 28, 2022	SELL	$0.73 - $1.27 $25,412 - $44,211	-34,812 Reduced 17.21%	167,510 $139,000

Q2 2022 Jul 25, 2022	SELL	$0.75 - $1.33 $70,068 - $124,253	-93,424 Reduced 31.59%	202,322 $156,000
Q1 2022 May 13, 2022	BUY	$1.09 - $1.83 $2,931 - $4,920	2,689 Added 0.92%	295,746 $384,000
Q4 2021 Feb 14, 2022	BUY	$1.63 - $2.83 $72,909 - $126,585	44,730 Added 18.01%	293,057 $481,000
Q3 2021 Nov 15, 2021	SELL	$2.45 - $3.45 $276,671 - $389,598	-112,927 Reduced 31.26%	248,327 $656,000
Q2 2021 Aug 16, 2021	BUY	$3.3 - $5.02 $37,138 - $56,495	11,254 Added 3.22%	361,254 $1.24 Million
Q1 2021 May 18, 2021	SELL	$4.29 - $9.94 $1.07 Million - $2.49 Million	-250,000 Reduced 41.67%	350,000 $1.76 Million
Q4 2020 Feb 16, 2021	BUY	$2.41 - $5.63 $1.45 Million - $3.38 Million	600,000 New	600,000 $2.82 Million

Others Institutions Holding EVGN

# of Institutions

Shares Held

4.08M

Call Options Held

23K

Put Options Held

View Full List

About Evogene Ltd.

Ticker EVGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,202,000
Market Cap $26.8M
Description
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...

More about EVGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverarc Capital Management, LLC with notifications on news.

Account

Silverarc Capital Management, LLC Evogene Ltd. Transaction History